CJC-1295: With and Without DAC - Research Comparison

CJC-1295: With and Without DAC - A Research Comparison

CJC-1295 is a synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH), also known as Growth Hormone Releasing Factor (GRF). It is primarily used in research settings to investigate growth hormone (GH) release and its downstream effects. There are two main variants of CJC-1295: one without Drug Affinity Complex (DAC), often referred to as Modified GRF 1-29 or simply CJC-1295 no DAC, and one with DAC, known as CJC-1295 with DAC. These two variants differ significantly in their pharmacokinetic profiles, affecting their research applications and the interpretation of results. This article provides a detailed comparison of both forms, focusing on their molecular structures, mechanisms of action, research applications, quality assessment, common impurities, and storage requirements.

Molecular Structure and Chemical Properties

Understanding the molecular structure is crucial for proper handling and interpretation of research data. Here's a breakdown of each variant:

CJC-1295 no DAC (Modified GRF 1-29)

Modified GRF 1-29 is a modified version of the first 29 amino acids of the endogenous GHRH. The key modifications include a D-Ala substitution at position 2 (Ala2) and the addition of a glutamine residue at position 8 (Gln8). These changes enhance its stability and resistance to degradation by peptidases.

• Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: Approximately 3368.0 g/mol
• Purity: Typically >98% by HPLC

CJC-1295 with DAC

CJC-1295 with DAC comprises Modified GRF 1-29 conjugated to a Drug Affinity Complex (DAC). The DAC moiety is a maleimidopropionic acid linked to human serum albumin (HSA). This conjugation increases the peptide's half-life in vivo by binding it to albumin, which is naturally present in the bloodstream.

• Sequence: Modified GRF 1-29 + DAC (Maleimidopropionic acid-HSA conjugate)
• Molecular Formula (without HSA portion): C₁₆₆H₂₇₃N₄₇O₄₇ (approximately – the DAC adds complexity)
• Molecular Weight (without HSA portion): Approximately 3649.3 g/mol (without the HSA portion) – the complete conjugate with HSA has a much higher molecular weight.
• Purity: Typically >98% by HPLC (referring to the Modified GRF 1-29 component, not the entire conjugate)

Mechanism of Action

Both CJC-1295 variants exert their effects by binding to the GHRH receptor in the anterior pituitary gland. This interaction stimulates the synthesis and secretion of GH. However, their pharmacokinetic profiles lead to distinct effects on GH release patterns.

CJC-1295 no DAC (Modified GRF 1-29)

Modified GRF 1-29 acts as a pulsatile GH secretagogue. It induces short bursts of GH release that mimic the natural pulsatile secretion pattern of GH. The half-life of Modified GRF 1-29 is relatively short, typically around 30 minutes.

CJC-1295 with DAC

The DAC moiety in CJC-1295 with DAC extends the half-life of the peptide significantly, to approximately 6-8 days. The DAC binds to albumin, which protects the peptide from degradation and elimination, leading to a more sustained release of GH. This results in elevated GH levels over a prolonged period, without mimicking the natural pulsatile release pattern.

Research Applications

The differing pharmacokinetic profiles of CJC-1295 with and without DAC make them suitable for different research applications.

CJC-1295 no DAC (Modified GRF 1-29)

• Studies of pulsatile GH secretion: Its short half-life makes it ideal for studying the dynamics of GH release and the effects of single, acute bursts of GH.
• Pharmacokinetic and pharmacodynamic studies: Researchers can use it to examine the effects of varying doses and administration schedules on GH release without the confounding factor of prolonged exposure.
• Investigation of GH-dependent signaling pathways: Because of its transient effect, it is useful for examining the immediate effects of GH on downstream signaling pathways.

CJC-1295 with DAC

• Long-term GH stimulation studies: Its extended half-life allows for the investigation of chronic GH elevation on various physiological processes.
• Studies on body composition and metabolism: Researchers can use it to examine the effects of sustained GH levels on fat mass, muscle mass, and metabolic parameters.
• Investigation of GH-dependent growth and development: Its prolonged action makes it suitable for studying the long-term effects of GH on growth and development in animal models.

Quality Markers to Look For

Ensuring the quality of CJC-1295 peptides is paramount for reliable research outcomes. Here are the key quality markers to assess:

• Purity (HPLC): High-Performance Liquid Chromatography (HPLC) is the gold standard for determining peptide purity. The purity should be clearly stated on the Certificate of Analysis (CoA) and should ideally be >98%. Look for a chromatogram showing a single major peak corresponding to the target peptide.
• Mass Spectrometry (MS): MS confirms the identity of the peptide by determining its molecular weight. The observed molecular weight should match the theoretical molecular weight within a narrow margin of error (typically ± 1 Da). The CoA should include MS data.
• Amino Acid Analysis (AAA): AAA verifies the amino acid composition of the peptide. The molar ratios of the amino acids should be consistent with the peptide sequence.
• Peptide Content: This indicates the actual amount of peptide present in the sample, accounting for water content and residual solvents. It is usually expressed as a percentage (e.g., 85% peptide content). A lower peptide content means you need to adjust your dosing calculations.
• Water Content (Karl Fischer Titration): Excessive water content can affect the stability and accuracy of peptide solutions. The water content should ideally be <5%.
• Acetate Content: Acetate is often used as a counterion during peptide synthesis. High acetate content can affect the pH of peptide solutions. The acetate content should be within acceptable limits (typically <15%).
• Endotoxin Levels (LAL Assay): Endotoxins are bacterial contaminants that can elicit an immune response. Endotoxin levels should be low (typically <10 EU/mg). This is especially important for in vivo studies.
• Appearance: The peptide should appear as a white to off-white powder or lyophilized cake. Discoloration or clumping may indicate degradation.
• Solubility: The peptide should readily dissolve in the appropriate solvent (e.g., sterile water, saline). Difficulty dissolving may indicate aggregation or degradation.

Common Impurities

Peptide synthesis is not perfect, and various impurities can be present in the final product. Identifying and minimizing these impurities is crucial for accurate research.

• Truncated Sequences: These are peptides with missing amino acids, often due to incomplete coupling during synthesis.
• Deletion Sequences: These are peptides with one or more amino acids missing from the sequence.
• Diastereomers: These are isomers that differ in the stereochemistry of one or more amino acids.
• Acetylation Products: Acetylation can occur at the N-terminus or on lysine side chains during synthesis.
• Oxidation Products: Oxidation can occur at methionine or tryptophan residues.
• Solvent Residues: Residual solvents from the synthesis process (e.g., DMF, acetonitrile) may be present.
• Counterions: Excess counterions (e.g., acetate, trifluoroacetate) may be present.

Practical Tip: Request a detailed impurity profile from the supplier. This profile should list the identity and quantity of any detectable impurities. A reputable supplier will provide this information transparently.

Storage Requirements

Proper storage is essential to maintain the integrity and stability of CJC-1295 peptides.

• Lyophilized Peptides: Store lyophilized peptides at -20°C or -80°C in a tightly sealed container, protected from moisture and light. Under these conditions, they can typically be stored for 1-2 years.
• Reconstituted Peptides: Once reconstituted in solution, peptides are more susceptible to degradation. Store reconstituted peptides at 4°C for short-term storage (up to a few days) or aliquot and store at -20°C or -80°C for longer-term storage (up to a few months). Avoid repeated freeze-thaw cycles.
• Solvent Considerations: Use sterile, endotoxin-free water or saline for reconstitution. The pH of the solvent can also affect stability. Consider buffering the solution to maintain a pH between 6 and 8.
• Container Considerations: Use sterile, pyrogen-free vials for storage. Glass vials are preferred over plastic vials, as they are less permeable to gases and solvents.

Practical Tip: Always record the date of reconstitution and any changes in appearance (e.g., discoloration, precipitation) to monitor the peptide's stability.

Comparison Table: CJC-1295 no DAC vs. CJC-1295 with DAC

Sourcing Considerations

Choosing a reliable supplier is crucial for obtaining high-quality CJC-1295 peptides. Consider the following factors:

• Reputation: Choose a supplier with a proven track record of providing high-quality peptides. Look for reviews and testimonials from other researchers.
• Certifications: Check if the supplier has certifications such as ISO 9001 or GMP compliance. These certifications indicate that the supplier adheres to quality management standards.
• Documentation: Ensure that the supplier provides a comprehensive Certificate of Analysis (CoA) for each batch of peptide. The CoA should include data on purity, molecular weight, amino acid analysis, water content, and endotoxin levels.
• Customer Support: Choose a supplier with responsive and knowledgeable customer support. They should be able to answer your questions about peptide quality, storage, and handling.
• Pricing: Compare prices from different suppliers, but be wary of prices that are significantly lower than the market average. This may indicate lower quality.
• Shipping and Handling: Ensure that the supplier uses appropriate shipping and handling procedures to protect the peptide from degradation during transit.

Practical Tip: Request a sample of the peptide before placing a large order to verify its quality. Perform your own in-house testing (e.g., HPLC) to confirm the supplier's CoA data.

Key Takeaways

• CJC-1295 exists in two main forms: with and without DAC.
• CJC-1295 no DAC (Modified GRF 1-29) has a short half-life and induces pulsatile GH release.
• CJC-1295 with DAC has a long half-life and induces sustained GH release.
• The choice between the two depends on the specific research question.
• Thorough quality assessment is crucial for reliable research outcomes.
• Proper storage is essential to maintain peptide integrity.
• Choose a reputable supplier with a proven track record of providing high-quality peptides.